Regenerative Medical Technology (RMTG) Capital Expenditures (2022 - 2026)
Regenerative Medical Technology (RMTG) recorded Capital Expenditures of $43,499 in Q2 2026, down 86.2% from the prior quarter.
Powered by 
Analysis
Regenerative Medical Technology (RMTG) Capital Expenditures (2022 - 2026) Analysis & Trends
On a TTM basis, Regenerative Medical Technology's Capital Expenditures came in at $850,894 as of Jun 30, 2026; for FY2025, it came in at $602,583, up 179.7% from FY2024.
- Annual Capital Expenditures has a three-year compound annual growth rate of 44.8% (FY2022 to FY2025).
- Across earlier years, Capital Expenditures came in at $215,419 in FY2024 (-44.1%), $385,596 in FY2023 (+94.3%) and $198,428 in FY2022.
- The Q2 2026 figure is the lowest quarterly Capital Expenditures since Q2 2023.
- On a year-over-year basis, Capital Expenditures rose in two of the last four quarters, with growth averaging 157.5%.
- Per Business Quant, the preceding three quarters came in at $315,394 (Q1 2026), $267,172 (Q4 2025) and $224,829 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 2.93 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 1.32 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 322.00 Mn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 893.00 Mn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | -321.00 Mn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | -763.00 Mn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 513.00 Mn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 140.00 Mn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 533.00 Mn |
| 10 | Regenerative Medical Technology | 824,338.06 | -3.70 Mn | 2.58 Mn | 43,499.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 43,499.00 |
| Mar 31, 2026 | 315,394.00 |
| Dec 31, 2025 | 267,172.00 |
| Sep 30, 2025 | 224,829.00 |
| Dec 31, 2024 | 50,000.00 |
| Sep 30, 2024 | 53,608.00 |
| Jun 30, 2024 | 52,657.00 |
| Mar 31, 2024 | 59,154.00 |
| Dec 31, 2023 | 284,002.00 |
| Sep 30, 2023 | 91,387.00 |
| Jun 30, 2023 | 4,721.00 |
| Mar 31, 2023 | 5,486.00 |
| Dec 31, 2022 | 68,527.00 |
| Sep 30, 2022 | 1,262.00 |
API Access
Regenerative Medical Technology Capital Expenditures API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=capital-expenditures&ticker=RMTG&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "capital-expenditures", "ticker": "RMTG", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=capital-expenditures&ticker=RMTG&period=max&api_key=YOUR_API_KEY");
const data = await res.json();